Jeffrey Gemi, MD, Ora Inc., speaks on the highlights from his presentation comparing Schirmer's test with other clinical outcomes in dry eye.
Jeffrey Gemi, MD, director of Special Projects, Anterior Segments, Ora Inc., speaks on the highlights from a presentation on comparing Schirmer's test with other clinical outcomes in dry eye during the virtual ARVO 2021 meeting.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.